{
    "root": "350a8419-40f4-f1a1-e063-6394a90ab585",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "PROGESTERONE",
    "value": "20250513",
    "ingredients": [
        {
            "name": "PROGESTERONE",
            "code": "4G7DS2Q64Y"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX"
        },
        {
            "name": "LECITHIN, SOYBEAN",
            "code": "1DI56QDM62"
        },
        {
            "name": "PEANUT OIL",
            "code": "5TL50QU0W4"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        }
    ],
    "indications": "Progesterone capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea.",
    "contraindications": "Prevention of Endometrial Hyperplasia\n                  Progesterone capsules should be given as a single daily dose at bedtime, 200 mg orally for 12 days sequentially per 28-day cycle, to postmenopausal women with a uterus who are receiving daily conjugated estrogens tablets.\n                  Treatment of Secondary Amenorrhea\n                  Progesterone capsules may be given as a single daily dose of 400 mg at bedtime for 10 days.\n                  Some women may experience difficulty swallowing progesterone capsules. For these women, progesterone capsules should be taken with a glass of water while in the standing position.",
    "warningsAndPrecautions": "Progesterone capsules, 200 mg are available as an oval white, opaque, capsule imprinted with P-4 in black ink.\n                  \n                     NDC 71335-2242-1: 30 Tablets in a BOTTLE\n                     NDC 71335-2242-2: 28 Tablets in a BOTTLE\n                     NDC 71335-2242-3: 18 Tablets in a BOTTLE\n                     NDC 71335-2242-4: 90 Tablets in a BOTTLE\n                     NDC 71335-2242-5: 100 Tablets in a BOTTLE\n                     NDC 71335-2242-6: 6 Tablets in a BOTTLE\n                     NDC 71335-2242-7: 60 Tablets in a BOTTLE\n                     NDC 71335-2242-8: 180 Tablets in a BOTTLE\n                  \n                  \n                  Store at 20째-25째C (68째-77째F). [See USP Controlled Room Temperature].\n  \n                     \nProtect from excessive moisture.\n \n                  Keep out of reach of children.\n                  Dispense in tight, light-resistant container as defined in USP/NF, accompanied by a Patient Insert.\n                  \n                  Repackaged/Relabeled by:\n  \nBryant Ranch Prepack, Inc.\n  \nBurbank, CA 9150",
    "adverseReactions": "Progesterone capsules should not be used in women with any of the following conditions:\n                  \n                     \n                        Progesterone capsules should not be used in patients with known hypersensitivity to its ingredients. Progesterone capsules contain peanut oil and should never be used by patients allergic to peanuts.\n                     \n                     Undiagnosed abnormal genital bleeding.\n                     Known, suspected, or history of breast cancer.\n                     Active deep vein thrombosis, pulmonary embolism or history of these conditions.\n                     Active arterial thromboembolic disease (for example, stroke and myocardial infarction), or a history of these conditions.\n                     Known liver dysfunction or disease.\n                     Known or suspected pregnancy."
}